Godrej Agrovet confirms no encumbrance on Astec shares in FY26
Godrej Agrovet Limited and its promoter group confirmed no encumbrance on Astec LifeSciences shares for FY26, complying with SEBI regulations.

*this image is generated using AI for illustrative purposes only.
Godrej Agrovet Limited, along with persons acting in concert, has confirmed that it has not created any encumbrance on its shareholding in astec lifesciences during the Financial Year 2025-26. This disclosure ensures that the promoter's holdings remain free from charges such as pledges or liens, which is critical for maintaining shareholder confidence and regulatory compliance.
The confirmation was submitted to BSE Limited and National Stock Exchange of India Limited on April 9, 2026. The filing was made in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation mandates promoters to disclose any encumbrance on their shareholding to ensure transparency in the capital markets.
The declaration covers Godrej Agrovet Limited and the extensive promoter group, including key individuals such as Nadir Barjorji Godrej, Adi Barjorji Godrej, and Nisaba Godrej. It also encompasses various group entities and trusts, confirming that no direct or indirect encumbrance was made on the shares during the specified financial year.
| Entity | Role | Status |
|---|---|---|
| Godrej Agrovet Limited | Promoter | No Encumbrance |
| Nadir Barjorji Godrej | Promoter | No Encumbrance |
| Adi Barjorji Godrej | Promoter | No Encumbrance |
| Nisaba Godrej | Promoter Group | No Encumbrance |
| Godrej Industries Limited | Promoter | No Encumbrance |
The disclosure was signed by Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, and submitted from Mumbai. This regulatory filing is part of the ongoing compliance requirements listed under the SEBI Takeover Regulations.
Historical Stock Returns for Astec Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.52% | -8.11% | -6.01% | +1.22% | -11.32% | -44.90% |
How might this clean shareholding status influence Godrej Agrovet's ability to raise capital for future acquisitions?
What impact will this disclosure have on shareholder confidence and Astec Lifesciences' stock performance?
Could this move signal potential strategic shifts or expansion plans by Godrej Agrovet in the agrochemical sector?































